• 1
    Helmstaedter C, Kurthen M. Memory and epilepsy: characteristics, course and influence of drugs and surgery. Curr Opin Neurol 2001;14: 2116.DOI: 10.1097/00019052-200104000-00013
  • 2
    Wilson BA, Clare L. Rehabilitation of memory disorders. In: GreenwoodR, BarnesM, McMillanTM, et al., eds. Handbook of neurological rehabilitation. 2nd ed. Hove , UK : Psychological Press, 2003: 37788.
  • 3
    Thompson PJ. Epilepsy and memory. In: CullC, GoldsteinL, eds. Clinical psychologists handbook of epilepsy. London : Routledge, 1997: 3553.
  • 4
    Meador K, Loring D. Cognitive effects of antiepileptic drugs. In: DevinskyO, TheodoreW, eds. Epilepsy and behavior. New York : Wiley-Liss, 1991: 15170.
  • 5
    Helmstaedter C, Kurthen M, Lux S, et al. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol 2003;54: 42532.DOI: 10.1002/ana.10692
  • 6
    Rausch R, Kraemer S, Pietras CJ, et al. Early and late cognitive changes following temporal lobe surgery. Neurology 2003;60: 9529.
  • 7
    Duncan JS. The cognitive consequences of epilepsy. Ann Neurol 2003;54: 4212.DOI: 10.1002/ana.10710
  • 8
    Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A 1993;90: 964953.
  • 9
    Mackenzie IR, Miller LA. Senile plaques in temporal lobe epilepsy. Acta Neuropathol (Berl) 1994;87: 50410.
  • 10
    Sheng JG, Boop FA, Mrak RE, et al. Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity. J Neurochem 1994;63: 18729.
  • 11
    Gouras GK, Relkin NR, Sweeney D, et al. Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques. Ann Neurol 1997;41: 4024.DOI: 10.1002/ana.410410317
  • 12
    Poirier J. Apoliprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994;17: 52530.DOI: 10.1016/0166-2236(94)90156-2
  • 13
    Aguglia U, Gambardella A, LePiane E, et al. Mild non-lesional temporal lobe epilepsy: a common, unrecognized disorder with onset in adulthood. Can J Neurol Sci 1998;25: 2826.
  • 14
    Gambardella A, Aguglia U, Cittadella R, et al. Apolipoprotein E polymorphisms and the risk of nonlesional temporal lobe epilepsy. Epilepsia 1999;40: 18047.
  • 15
    Gambardella A, Manna I, Labate A, et al. GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy. Neurology 2003;60: 5603.
  • 16
    Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30: 38999.
  • 17
    Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12: 18998.DOI: 10.1016/0022-3956(75)90026-6
  • 18
    Rey A. Mémorisation d'une série de 15 mots en 5 répétitions. In: ReyA, ed. L'examen clinique en psychologie. Paris : Presses Universitaire de France , 1958.
  • 19
    Caltagirone C, Gainotti G, Masullo C, et al. Validity of some neuropsychological tests in the assessment of mental deterioration. Acta Psychol Scand 1979;60: 506.
  • 20
    Corsi P. Interhemispheric differences in the localization of psychological processes in man. Thesis. Montreal : University of Montreal , 1972.
  • 21
    Borkowsky JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologia 1967;5: 13540.
  • 22
    Gainotti G, Caltagirone C, Miceli G. Sui rapporti fra alcune prove di intelligenza verbale e lesioni focali monoemisferiche. Acta Neurol 1976;31: 37081.
  • 23
    Raven JC. Progressive matrices: sets A, AbB. In: LewisHK, ed. Board and book forms. London : 1947.
  • 24
    Heaton RK. Wisconsin Card Sorting Test manual. In: Psychological assessment resources. Odessa , FL : 1981.
  • 25
    De Renzi E, Vignolo LA. The Token test: a sensitive test to detect receptive disturbances in aphasia. Brain 1962;85: 66578.
  • 26
    Stroop JR. Studies of interference in serial verbal reaction. J Exp Psychol 1935;18: 64362.
  • 27
    Spinnler H, Tognoni G. Standardizzazione e taratura italiana dei test neuropsicologici. Italy J Neurol Sci 1987;6: 820.
  • 28
    Carlesimo GA, Caltagirone C, Gainotti G. The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. Eur Neurol 1996;36: 37884.
  • 29
    Grigoletto F, Zappala G, Anderson DW, et al. Norms for the Mini-Mental State Examination in a healthy population. Neurology 1999;53: 31520.DOI: 10.1159/000006604
  • 30
    Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;5: 5662.
  • 31
    Wenham PR, Price WH, Blundel G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337: 11589.DOI: 10.1016/0140-6736(91)92823-K
  • 32
    Ardlie KG, Lunetta KL, Seielstad M. Testing for population subdivision and association in four case-control studies. Am J Hum Genet 2002;71: 30411.DOI: 10.1086/341719
  • 33
    Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992;48: 36172.
  • 34
    Muros M, Rodigruez-Ferre C. Apolipoprotein E polymorphism influence on lipids, apoliproteins and Lp(a) in a Spanish population underexpressing ApoE ɛ4. Atherosclerosis 1996;121: 1321.DOI: 10.1016/0021-9150(95)06643-8
  • 35
    Mattson MP, Cheng B, Davis D, et al. Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitoxicity. J Neurosci 1992;12: 37689.
  • 36
    Meyer MR, Tschanz JT, Norton MC, et al. ApoE genotype predicts when—not whether— one is predisposed to develop Alzheimer's disease. Nat Genet 1998;19: 3212.
  • 37
    Teasdale GM, Nicoll JA, Murray G, et al. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997;350: 106971.DOI: 10.1016/S0140-6736(97)04318-3
  • 38
    Caselli RJ, Reiman EM, Osborne D, et al. Longitudinal changes in cognition and behavior in asymptomatic carriers of the ApoE ɛ4 allele. Neurology 2004;62: 19905.
  • 39
    Kalviainen R, Partanen K, Aikia M, et al. Apolipoprotein E polymorphism in relation to hippocampal cell damage and memory impairment in newly diagnosed partial epilepsy. Neurology 1998;50: A1412.DOI: 10.1159/000023262
  • 40
    Briellmann RS, Torn-Broers Y, Busuttil BE, et al. ApoE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology 2000;55: 4357.
  • 41
    Bengzon J, Kokaia Z, Elmer E, et al. Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci U S A 1997;94: 104327.
  • 42
    Chang YC, Huang AM, Kuo YM, et al. Febrile seizures impair memory and cAMP response-element binding protein activation. Ann Neurol 2003;54: 70618.
  • 43
    Briellmann RS, Berkovic SF, Syngeniotis A, et al. Seizure-associated hippocampal volume loss: a longitudinal magnetic resonance study of temporal lobe epilepsy. Ann Neurol 2002 Dec; 52(6): 861; author reply 862.DOI: 10.1002/ana.10408
  • 44
    Liu RS, Lemieux L, Bell GS, et al. Progressive neocortical damage in epilepsy. Ann Neurol 2003;53: 31224.DOI: 10.1002/ana.10463
  • 45
    O'Dougherty M, Wright FS, Cox S, et al. Carbamazepine plasma concentration: relationship to cognitive impairment. Arch Neurol 1987;44: 8637.
  • 46
    Meador KJ. Cognitive outcomes and predictive factors in epilepsy. Neurology 2002;58(suppl 5):S216.
  • 47
    Currie S, Heathfield KW, Henson RA, et al. Clinical course and prognosis of temporal lobe epilepsy: a survey of 666 patients. Brain 1971;94: 17390.
  • 48
    Hauser WA, The natural history of temporal lobe epilepsy. In: LüdersHO, ed. Epilepsy surgery. New York : Raven Press, 1992: 13341.
  • 49
    King MA, Newton MR, Jackson GD, et al. Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet 1998;352: 100711.DOI: 10.1016/S0140-6736(98)03543-0
  • 50
    Berkovic S, McIntosh A, Howell RA, et al. Familial temporal lobe epilepsy: a common disorder identified in twins. Ann Neurol 1996;40: 22735.
  • 51
    Vadlamudi L, Scheffer IE, Berkovic SF. Genetics of temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2003;74: 135961.DOI: 10.1136/jnnp.74.10.1359
  • 52
    Koutroumanidis M, Hennessy MJ, Seed PT, et al. Significance of interictal bilateral temporal hypometabolism in temporal lobe epilepsy. Neurology 2000;54: 181121.
  • 53
    Katzman R. Education and the prevalence of dementia and Alzheimer's disease. Neurology 1993;43: 1320.
  • 54
    Kanemoto K, Kawasaki J, Miyamoto T, et al. Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol 2000;47: 5714.DOI: 10.1002/1531-8249(200005)47:5<571::AID-ANA3>3.3.CO;2-1
  • 55
    Stogmann E, Zimprich A, Baumgartner C, et al. A functional polymorphism in the prodynorphin gene promotor is associated with temporal lobe epilepsy. Ann Neurol 2002;51: 2603.DOI: 10.1002/ana.10108
  • 56
    Walz R, Castro RM, Velasco TR, et al. Surgical outcome in mesial temporal sclerosis correlates with prion protein gene variant. Neurology 2003;61: 120410.
  • 57
    Dahlman I, Eaves IA, Kosoy R, et al. Parameters for reliable results in genetic association studies in common disease. Nat Genet 2002;30: 14950.DOI: 10.1038/ng825